Search
Close this search box.
Search
Close this search box.

OUR STORY

Our Story

Built on the experience and know-how of our founding companies, SEKISUI Medical Group is a diverse, global network committed to improving health outcomes and the well-being of people worldwide.

Relationships are the cornerstone of our business. Our global reach allows us to form relationships that help us refine and innovate products and services to constantly improve the quality of results we deliver.

From its founding in 1947, our parent company, SEKISUI Chemical, was dedicated to bettering the world, not just for the present but for generations to come. It’s a philosophy we still live by today as we care for the environment we share, help build an equitable society, and focus on the governance that keeps us aware of our company’s effect on the world around us.

We believe that providing intelligent solutions starts with listening. We earn our customers’ trust by committing to quality through creative thinking, intelligent problem-solving, products that operate with precision, and comprehensive services.

SEKISUI Medical Group is committed to making an impact in our industry by evolving the science of health—because lives depend on it.

History & milestones

ellipse
1947
Sekisui Chemical established

Corporate philosophy: to create social value through corporate activities.

1947
Daiichi Pure Chemicals established
Start of domestic production of in-vitro diagnostic reagents in Japan.
ellipse
ellipse
1979
Diversification into medical market
Sekisui Chemical diversifies into the medical market.
1984
Medical and diagnostics business established
Sekisui Chemical establishes a medical business division and launches a diagnostics business.
ellipse
ellipse
2006
Group expansion with Daiichi Pure Chemicals
Daiichi Pure Chemicals becomes part of the SEKISUI Group.
ellipse
2008
Sekisui Medical established
Merger of SEKISUI Chemical’s Medical Business Division and Daiichi Pure Chemicals.
XenoTech joins the SEKISUI Medical Group
Acquired US-based Xenotech.
2010
Sekisui Medical Technology (China) established
Merger of Beijing SEKISUI Trank Medical Technology (a SEKISUI Chemical subsidiary) and Shanghai Daiichi Diagnostics (a SEKISUI Medical subsidiary company).
ellipse
ellipse
2011
Sekisui Diagnostics established
After acquisition of the Diagnostics Division of US-based Genzyme Corporation, SEKISUI Diagnostics was established.
2015
Sekisui Medical Technology (Suzhou) established
SEKISUI Medical Technology (Suzhou) Co., Ltd was established.
EIDIA joins the SEKISUI Medical Group
Acquired EIDIA, Japan clinical diagnostic reagent company.
ellipse
ellipse
2017
Sekisui Medical merges with EIDIA
SEKISUI Medical is merged with EIDIA.
ellipse
2018
Veredus Laboratories joins the SEKISUI Medical Group
Singapore-based Veredus Laboratories is acquired.

See here for individual Group companies